Vorotek vs Zephyr: ENT Suction Device Comparison

Key Takeaways:

• Zephyr has University of Salford independent acoustic testing (n=30, all p < 0.001); Vorotek has no equivalent independently published data available
• Zephyr offers fingertip variable airflow control and single-use sterile packs; Vorotek uses traditional suction regulation with reusable components requiring decontamination
• Zephyr holds CE Mark / UKCA Class II approval for all surgical suction applications; Vorotek’s specific approval scope should be confirmed with the manufacturer
• For procurement teams under ENT UK 2024 guidance, the ability to reference independently verified performance data provides a defensible equipment selection

Hospital procurement teams and ENT surgeons evaluating suction equipment face a decision that affects every procedure performed in their department. The choice of suction device influences noise exposure for patients and theatre staff, procedural precision, infection control workflows, and compliance with professional guidance.

This article compares what is publicly known about Vorotek suction devices and the Zephyr from Spoke Medical, identifies where independent evidence exists and where it does not, and sets out the evaluation framework that procurement teams should apply.

Overview of Each Device

Vorotek

Vorotek manufactures suction devices used in some UK ENT departments. The company offers various models designed for ENT and microsuction applications. Vorotek devices use traditional suction control approaches and are available through established medical equipment channels.

Zephyr (Spoke Medical)

The Zephyr is designed for ENT suction applications with noise reduction engineered as a core design principle. It features fingertip variable airflow control, patented anti-block technology, and single-use sterile consumable packs. The device holds CE Mark and UKCA Class II approval for all surgical suction applications and is manufactured under ISO 13485. Its clinical advisory board includes Patrick Axon and Neil Donnelly.

Comparison Table

Independent Acoustic Evidence

For any suction device used in surgical and clinical settings, noise performance is a patient safety issue and an occupational health consideration. The question is not simply which device sounds quieter in use, but which device has rigorous, independently verified acoustic data to support its performance claims.

The Zephyr has been tested by the University of Salford Acoustics Calibration Laboratory in a hemi-anechoic chamber. The study measured 30 procedures at 1/32-second temporal resolution across three defined phases: device insertion/startup, idle, and active suction. All comparisons between the Zephyr and a traditional suction baseline achieved statistical significance at p < 0.001 using Welch t-tests. The key findings include:

• 24.9 dB overall reduction (93.4 vs 118.3 dB LAeq), representing approximately 8 times lower sound pressure
• 43.5 dB reduction at insertion (65.0 vs 108.5 dBA), the phase where patient startle risk is highest
• Peak LAmax of 114.1 dB compared to 136.9 dB for traditional devices

For Vorotek devices, no equivalent independently published acoustic testing data from an accredited laboratory is readily available. This is not a claim that Vorotek devices are necessarily loud. It is an observation that procurement teams evaluating noise performance will find published, peer-reviewable data for the Zephyr and not for Vorotek. In the context of ENT UK 2024 guidance, which specifically addresses noise as a safety concern, this evidence gap is relevant.

Suction Control in Surgical Settings

Surgical suction demands vary continuously. Clearing a field of blood requires different suction intensity than working adjacent to the tympanic membrane or managing tissue near the facial nerve. The ability to modulate airflow in real time without stepping away from the operative field directly affects procedural precision.

Vorotek devices use traditional suction regulation. Adjustments are made through conventional mechanisms separate from the handpiece.

The Zephyr integrates fingertip variable airflow control into the handpiece itself. The surgeon modulates suction intensity through thumb pressure during the procedure, enabling real-time transitions between aggressive clearance and delicate work without repositioning hands or reaching for external controls. For procedures such as tympanoplasty, ossiculoplasty, or cholesteatoma excision, where suction requirements change moment to moment, this integrated control can reduce procedural interruptions.

Infection Control and Decontamination

In hospital ENT departments, infection control is governed by rigorous protocols. The choice between reusable and single-use suction pathways has implications for both compliance and operational efficiency.

Vorotek devices use reusable components. After each patient, suction pathways must be decontaminated according to hospital protocols. This involves disassembly, cleaning, disinfection or sterilisation, drying, reassembly, and documentation. Each decontamination cycle consumes staff time and sterile services resources, and introduces a reliance on consistent protocol adherence to maintain sterility assurance.

The Zephyr uses single-use sterile packs. Each procedure begins with a factory-sealed consumable set, eliminating the decontamination pathway for suction components. This provides an auditable chain of sterility for every patient encounter, reduces turnaround time between procedures, and removes the risk of residual contamination from incomplete decontamination. For departments managing high procedure volumes, the operational efficiency gain can be significant.

Surgical Application Breadth

The scope of regulatory approval determines where a device can be used across a department’s case mix.

Vorotek devices are used in ENT suction applications. The specific scope of regulatory approval for each model should be confirmed with the manufacturer.

The Zephyr holds CE Mark and UKCA Class II approval for all surgical suction applications. This means a single device platform can be used across cerumen management, FESS, middle ear surgery, post-operative debridement, and any other procedure requiring surgical suction. For departments seeking to standardise equipment and reduce the number of different devices in their inventory, this breadth of approval simplifies procurement, training, and maintenance.

ENT UK 2024 Guidance Alignment

The ENT UK 2024 position statement on microsuction and suction safety establishes expectations for noise management and equipment standards. Departments procuring new suction equipment should consider whether their chosen device demonstrably meets this guidance.

The Zephyr’s independently verified acoustic data and operational noise profile (at or below 75 dB during non-active phases) provide documented evidence of compliance. For Vorotek devices, public documentation confirming alignment with ENT UK 2024 guidance is not readily available. Procurement teams should request this information directly from the manufacturer.

What Procurement Teams Should Evaluate

When comparing suction devices for hospital ENT departments, the following evaluation criteria should form the basis of the procurement decision:

1. Independent acoustic evidence — Request published test reports from accredited laboratories. Manufacturer claims without independent verification should be weighted accordingly.
2. Phase-by-phase noise data — A single average noise figure can mask dangerous peaks. Require data for startup, idle, and active suction separately.
3. Control mechanism — Assess whether suction can be modulated in real time from the handpiece during surgical procedures.
4. Sterility pathway — Compare the total cost and operational burden of reusable decontamination versus single-use consumables. Include staff time, materials, equipment, and compliance documentation.
5. Regulatory approval scope — Confirm that the device is approved for the full range of surgical applications performed by the department, not only cerumen removal.
6. ENT UK 2024 compliance — Request documentation confirming alignment with current professional guidance.
7. Clinical advisory support — Evaluate the manufacturer’s clinical support infrastructure, including advisory board expertise and training provision.
8. Total cost of ownership — Model the full cost over three to five years, including consumables, decontamination, maintenance, and the operational value of time savings.

The Procurement Decision

Both Vorotek and Zephyr are used in UK ENT settings, but they present procurement teams with a fundamental question: how much weight should be given to independently verified performance data?

The Zephyr offers published acoustic data from an accredited university laboratory, fingertip variable airflow control, single-use sterile consumables, and CE Mark / UKCA Class II approval spanning all surgical suction. Vorotek offers an established presence in some ENT departments with a traditional approach to suction control and decontamination.

For procurement teams operating under ENT UK 2024 guidance and institutional governance requirements, the ability to demonstrate evidence-based equipment selection is increasingly important. A device with independently published performance data provides a defensible procurement decision. A device without equivalent data may still perform well in practice, but the absence of verifiable evidence makes it harder to justify the selection against current standards.